Slate Path Capital LP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:05 pm Sale | 2024-11-30 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 0 0.000% | -357,880 (Position Closed) | Filing |
| 2024-01-22 3:44 pm Purchase | 2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 357,880 14.600% | 357,880 (New Position) | Filing |